Orecchia, P.;                     Balza, E.;                     Pietra, G.;                     Conte, R.;                     Bizzarri, N.;                     Ferrero, S.;                     Mingari, M.C.;                     Carnemolla, B.    
        L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model. Cancers 2019, 11, 1232.
    https://doi.org/10.3390/cancers11091232
    AMA Style
    
                                Orecchia P,                                 Balza E,                                 Pietra G,                                 Conte R,                                 Bizzarri N,                                 Ferrero S,                                 Mingari MC,                                 Carnemolla B.        
                L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model. Cancers. 2019; 11(9):1232.
        https://doi.org/10.3390/cancers11091232
    
    Chicago/Turabian Style
    
                                Orecchia, Paola,                                 Enrica Balza,                                 Gabriella Pietra,                                 Romana Conte,                                 Nicolò Bizzarri,                                 Simone Ferrero,                                 Maria Cristina Mingari,                                 and Barbara Carnemolla.        
                2019. "L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model" Cancers 11, no. 9: 1232.
        https://doi.org/10.3390/cancers11091232
    
    APA Style
    
                                Orecchia, P.,                                 Balza, E.,                                 Pietra, G.,                                 Conte, R.,                                 Bizzarri, N.,                                 Ferrero, S.,                                 Mingari, M. C.,                                 & Carnemolla, B.        
        
        (2019). L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model. Cancers, 11(9), 1232.
        https://doi.org/10.3390/cancers11091232